Chairmans and MDs address to shareholders
Filed with ASX · · 25 pages · English
Please find attached copies of the Chairman’s Address and Managing Director’s presentation slides to be presented at CSL’s Annual General Meeting which commences at 10.00 a.m. today. Edward Bailey Company Secretary Chairman’s Address Annual General Meeting – 19 October 2011 “I am pleased to report that CSL achieved international sales growth for our plasma products this year, in both established a
Earlier from CSL
- Appointment of Paul Perreault as Executive Director
- New US$500 million Private Placement
- Full Year Results, Appendix 4E and Analysts Presentation
- CSL Settles US Class Action and Updated Profit Guidance
- Half Yearly Report and Accounts
Later from CSL
- Recombinant Technologies
- Chairman`s Address to Shareholders
- CSL to acquire Novartis influenza vaccine business
- IDELVION(R) (rFIX-FP) - European Commission Approval
- Flucelvax Quadrivalent (Influenza Vaccine) - FDA Approval
Follow CSL into a list and get an email when it puts out news.
Follow CSL